Page last updated: 2024-08-23

bucindolol and Left Ventricular Dysfunction

bucindolol has been researched along with Left Ventricular Dysfunction in 10 studies

Research

Studies (10)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's7 (70.00)29.6817
2010's3 (30.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Aleong, RG; Bristow, MR; Davis, G; Sauer, WH1
Adams, KF1
Remme, WJ1
Francis, GS; Sarraf, M1
Ball, S; Berning, J; Brendorp, B; Carlsen, J; Eberle, S; Hall, A; Hampton, J; Jensen, G; Køber, L; Ottesen, M; Torp-Pedersen, C; Zilles, P1
Adams, K; Ghali, JK; Goldman, S; Khan, S; Krause-Steinrauf, HJ; Larsen, RL; Lindenfeld, J; Lowes, B; Peberdy, MA; Rosenberg, YD; Thaneemit-Chen, S; Yancy, C; Young, J1
Coffey, CS; Curtis, JP; Foody, JM; Hebert, PR; Ko, DT; Krumholz, HM; Sedrakyan, A1
Coutinho, J1
Czuriga, I; Edes, I1
Yancy, CW1

Reviews

5 review(s) available for bucindolol and Left Ventricular Dysfunction

ArticleYear
Beta-blockers in heart failure: how far have we progressed?
    Postgraduate medicine, 2002, Volume: 112, Issue:5 Suppl Un

    Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Bisoprolol; Carbazoles; Carvedilol; Contraindications; Heart Failure; Humans; Metoprolol; Propanolamines; Sympathetic Nervous System; Ventricular Dysfunction, Left

2002
β-blockers in stage B: a precursor of heart failure.
    Heart failure clinics, 2012, Volume: 8, Issue:2

    Topics: Adrenergic beta-Antagonists; Animals; Benzazepines; Bisoprolol; Carbazoles; Cardiovascular System; Carvedilol; Disease Progression; Heart Failure; Heart Ventricles; Humans; Ivabradine; Propanolamines; Sympathetic Nervous System; Ventricular Dysfunction, Left

2012
[Adrenergic beta inhibitors in heart insufficiency: which and when?].
    Revista portuguesa de cardiologia : orgao oficial da Sociedade Portuguesa de Cardiologia = Portuguese journal of cardiology : an official journal of the Portuguese Society of Cardiology, 2001, Volume: 20 Suppl 3

    Topics: Adrenergic beta-Antagonists; Bisoprolol; Carbazoles; Carvedilol; Heart Failure; Humans; Metoprolol; Patient Selection; Propanolamines; Randomized Controlled Trials as Topic; Sympathetic Nervous System; Ventricular Dysfunction, Left

2001
[Role of beta-blockers in the treatment of chronic heart heart failure].
    Orvosi hetilap, 2001, Sep-16, Volume: 142, Issue:37

    Topics: Adrenergic beta-Antagonists; Bisoprolol; Carbazoles; Carvedilol; Chronic Disease; Controlled Clinical Trials as Topic; Disease Progression; Drug Administration Schedule; Heart Failure; Humans; Metoprolol; Myocardial Contraction; Patient Selection; Propanolamines; Survival Rate; Ventricular Dysfunction, Left; Ventricular Function, Left

2001
The role of race in heart failure therapy.
    Current cardiology reports, 2002, Volume: 4, Issue:3

    Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Black People; Coronary Artery Disease; Heart Failure; Humans; Hypertension; Incidence; Prognosis; Propanolamines; Racial Groups; Randomized Controlled Trials as Topic; Risk Factors; Ventricular Dysfunction, Left

2002

Trials

3 trial(s) available for bucindolol and Left Ventricular Dysfunction

ArticleYear
New-onset atrial fibrillation predicts heart failure progression.
    The American journal of medicine, 2014, Volume: 127, Issue:10

    Topics: Adrenergic beta-Antagonists; Aged; Atrial Fibrillation; Disease Progression; Female; Heart Failure; Humans; Male; Middle Aged; Multivariate Analysis; Prognosis; Propanolamines; Proportional Hazards Models; Risk Factors; Ventricular Dysfunction, Left

2014
The incomplete bucindolol evaluation in acute myocardial infarction Trial (BEAT).
    European journal of heart failure, 2002, Volume: 4, Issue:4

    Topics: Adrenergic beta-Antagonists; Adult; Aged; Aged, 80 and over; Drug Therapy, Combination; Female; Heart Failure; Humans; Male; Middle Aged; Myocardial Contraction; Myocardial Infarction; Propanolamines; Survival Rate; Ventricular Dysfunction, Left; Ventricular Function, Left

2002
Adverse effects of beta-blocker therapy for patients with heart failure: a quantitative overview of randomized trials.
    Archives of internal medicine, 2004, Jul-12, Volume: 164, Issue:13

    Topics: Adrenergic beta-Antagonists; Aged; Bisoprolol; Bradycardia; Carbazoles; Carvedilol; Dizziness; Fatigue; Female; Follow-Up Studies; Heart Conduction System; Heart Failure; Humans; Hypotension; Male; Metoprolol; Middle Aged; Propanolamines; Risk Factors; Risk Reduction Behavior; Severity of Illness Index; Statistics as Topic; Treatment Failure; Ventricular Dysfunction, Left; Withholding Treatment

2004

Other Studies

2 other study(ies) available for bucindolol and Left Ventricular Dysfunction

ArticleYear
Which beta-blocker is most effective in heart failure?
    Cardiovascular drugs and therapy, 2010, Volume: 24, Issue:4

    Topics: Adrenergic beta-Antagonists; Animals; Benzopyrans; Bisoprolol; Carbazoles; Carvedilol; Clinical Trials as Topic; Comorbidity; Diabetes Mellitus; Disease Progression; Ethanolamines; Heart Failure; Humans; Lung Diseases, Obstructive; Metoprolol; Myocardial Infarction; Nebivolol; Propanolamines; Treatment Outcome; Ventricular Dysfunction, Left; Ventricular Remodeling

2010
Hormone replacement therapy is associated with improved survival in women with advanced heart failure.
    Journal of the American College of Cardiology, 2003, Oct-01, Volume: 42, Issue:7

    Topics: Aged; Aged, 80 and over; Arizona; California; Colorado; Estrogen Replacement Therapy; Female; Heart Failure; Humans; Louisiana; Maryland; Middle Aged; North Carolina; Ohio; Postmenopause; Prognosis; Propanolamines; Proportional Hazards Models; Randomized Controlled Trials as Topic; Retrospective Studies; Survival Analysis; Systole; Texas; Ventricular Dysfunction, Left; Virginia; Women's Health

2003